AAAAAA

   
Results: << | 201-225 | 226-250 | 251-275 | 276-300 | >>

Table of contents of journal: The *Prostate

Results: 201-225/1162

Authors: Dawkins, HJS Sellner, LN Turbett, GR Thompson, CA Redmond, SL McNeal, JE Cohen, RJ
Citation: Hjs. Dawkins et al., Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecularmarkers of cancer progression, PROSTATE, 44(4), 2000, pp. 265-270

Authors: Filella, X Alcover, J Zarco, MA Beardo, P Molina, R Ballesta, AM
Citation: X. Filella et al., Analysis of type T1 and T2 cytokines in patients with prostate cancer, PROSTATE, 44(4), 2000, pp. 271-274

Authors: Williams, JF Muenchen, HJ Kamradt, JM Korenchuk, S Pienta, KJ
Citation: Jf. Williams et al., Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: An experimental study, PROSTATE, 44(4), 2000, pp. 275-278

Authors: Carlsson, L Pahlson, C Bergquist, M Ronquist, G Stridsberg, M
Citation: L. Carlsson et al., Antibacterial activity of human prostasomes, PROSTATE, 44(4), 2000, pp. 279-286

Authors: Gunawardena, K Murray, DK Meikle, AW
Citation: K. Gunawardena et al., Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis, PROSTATE, 44(4), 2000, pp. 287-295

Authors: Scott, KM Fanta, P Calaluce, R Dalkin, B Weinstein, RS Nagle, RB
Citation: Km. Scott et al., Diagnostic frozen prostate sextant biopsies: An approach for preserving protein and RNA for additional studies, PROSTATE, 44(4), 2000, pp. 296-302

Authors: Liu, AY LaTray, L van den Engh, G
Citation: Ay. Liu et al., Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells, PROSTATE, 44(4), 2000, pp. 303-312

Authors: Schipper, RG Deli, G Deloyer, P Lange, WPHJ Schalken, JA Verhofstad, AAJ
Citation: Rg. Schipper et al., Antitumor activity of the polyamine analog N-I,N-II-diethylnorspermine against human prostate carcinoma cells, PROSTATE, 44(4), 2000, pp. 313-321

Authors: Fukuda, H Yamada, T Kamata, S Saitoh, H
Citation: H. Fukuda et al., Anatomic distribution of intraprostatic lymphatics: Implications for the lymphatic spread of prostate cancer - A preliminary study, PROSTATE, 44(4), 2000, pp. 322-327

Authors: Takahashi, N Shimizu, T Takeda, K
Citation: N. Takahashi et al., Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells, PROSTATE, 44(4), 2000, pp. 328-333

Authors: Ropiquet, F Giri, D Kwabi-Addo, B Schmidt, K Ittmann, M
Citation: F. Ropiquet et al., FGF-10 is expressed at low levels in the human prostate, PROSTATE, 44(4), 2000, pp. 334-338

Authors: Bohlen, D Hugonnet, CL Mills, RD Weise, ES Schmid, HP
Citation: D. Bohlen et al., Five meters of H2O: The pressure at the urinary bladder neck during human ejaculation, PROSTATE, 44(4), 2000, pp. 339-341

Authors: Abrahamsson, PA Dizeyi, N Alm, P di Sant'Agnese, PA Deftos, LJ Aumuller, G
Citation: Pa. Abrahamsson et al., Calcitonin and calcitonin gene-related peptide in the human prostate gland, PROSTATE, 44(3), 2000, pp. 181-186

Authors: O'Donnell, RT DeNardo, SJ DeNardo, GL Miers, L Lamborn, KR Kukis, DL Meyers, FJ
Citation: Rt. O'Donnell et al., Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice, PROSTATE, 44(3), 2000, pp. 187-192

Authors: Lin, VK Wang, D Lee, IL Vasquez, D Fagelson, JE McConnell, JD
Citation: Vk. Lin et al., Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue, PROSTATE, 44(3), 2000, pp. 193-203

Authors: Cohen, RJ Holland, JW Redmond, SL McNeal, JE Dawkins, HJS
Citation: Rj. Cohen et al., Identification of the glycosaminoglycan keratan sulfate in the prostatic secretory cell, PROSTATE, 44(3), 2000, pp. 204-209

Authors: Okegawa, T Noda, H Kato, M Miyata, A Nutahara, K Higashihara, E
Citation: T. Okegawa et al., Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer, PROSTATE, 44(3), 2000, pp. 210-218

Authors: Schatzl, G Reiter, WJ Thurridl, T Waldmuller, J Roden, M Soregi, S Madersbacher, S
Citation: G. Schatzl et al., Endocrine patterns in patients with benign and malignant prostatic diseases, PROSTATE, 44(3), 2000, pp. 219-224

Authors: Yonese, J Kihara, K Sato, K Fukuda, H Kamata, S Oshima, H
Citation: J. Yonese et al., Sympathetic efferent pathways projecting to the prostate in the dog, PROSTATE, 44(3), 2000, pp. 225-232

Authors: Span, PN van Bokhoven, A Smals, AGH Sweep, CGJ Schalken, JA
Citation: Pn. Span et al., Partial sequencing and tissue distribution of the canine isoforms of steroid 5 alpha-reductase type I and type II, PROSTATE, 44(3), 2000, pp. 233-239

Authors: Zermann, DH Ishigooka, M Doggweiler, R Schubert, J Schmidt, RA
Citation: Dh. Zermann et al., Central nervous system neurons labeled following the injection of pseudorabies virus into the rat prostate gland, PROSTATE, 44(3), 2000, pp. 240-247

Authors: Kumar, A Mikolajczyk, SD Hill, TM Millar, LS Saedi, MS
Citation: A. Kumar et al., Different proportions of various prostate-specific antigen (PSA) and humankallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells, PROSTATE, 44(3), 2000, pp. 248-254

Authors: Schroder, FH Alexander, FE Bangma, CH Hugosson, J Smith, DS
Citation: Fh. Schroder et al., Screening and early detection of prostate cancer, PROSTATE, 44(3), 2000, pp. 255-263

Authors: Thalmann, GN Sikes, RA Wu, TT Degeorges, A Chang, SM Ozen, M Pathak, S Chung, LWK
Citation: Gn. Thalmann et al., LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis, PROSTATE, 44(2), 2000, pp. 91-103

Authors: Goulas, A Hatzichristou, DG Karakiulakis, G Mirtsou-Fidani, V Kalinderis, A Papakonstantinou, E
Citation: A. Goulas et al., Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution, PROSTATE, 44(2), 2000, pp. 104-110
Risultati: << | 201-225 | 226-250 | 251-275 | 276-300 | >>